(+)-Chloro(p-menth-3-yloxy)dimethylsilane
CAS: 19470-77-0
Ref. TR-C194705
1g | Ausgelaufen | ||
100mg | Ausgelaufen | ||
500mg | Ausgelaufen |
Produktinformation
- [1R-(1α,2β,5α)]-Chlorodimethyl[[5-methyl-2-(1-methylethyl)cyclohexyl]oxy]silane
Applications (+)-Chloro(p-menth-3-yloxy)dimethylsilane is a byproduct in the synthesis of Carfilzomib (2R,4R)-Diol (C183525), which is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);